Tina
★    

India,
2016-05-26 15:58
(3324 d 10:28 ago)

Posting: # 16363
Views: 2,624
 

 Biowaiver for one strength/dose of non-linear PK [Design Issues]

Dear all,
Iam currently working on a BE study (with an anticancer drug) in cancer patients for EU submission. A higher dose is linear whilst the lower dose (in a different group of cancer patients) is non-linear. BE study with a higher dose can be planned. However, being rare condition, lower dose/strength cant be planned. Could the group members kindly help with providing a solution to waive BE study with the lower dose/strength (with non-linear pk) please? The irony is some patients in the main indication could also receive the lower dose/strength…recruitment of such patients will still be an issue. Has anyone received biowaiver for non-linear PK drug by conduct of a single study and justifying the non-conduct of the other?
Thank you for the kind help.
Kind regards,
Tina


Edit: Category changed; see also this post #1. [Helmut]
UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,684 registered users;
59 visitors (0 registered, 59 guests [including 10 identified bots]).
Forum time: 02:27 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5